The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
ARCA biopharma, Inc(NASDAQ:ABIO)

ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase 2 clinical trial for the treatme...
Website: http://arcabio.com
Founded: 2004
Full Time Employees: 13
Sector: Healthcare
Industry: Biotechnology
ARCA biopharma Days Payable Outstanding ttm (DPO)
ARCA biopharma Op Cashflow Per Share ttm
ARCA biopharma Free Cashflow Per Share ttm
ARCA biopharma Cash Per Share ttm
ARCA biopharma (GAAP) P/E ratio ttm
ARCA biopharma P/B ratio ttm
No extra charts and metrics for this ticker.